sulforaphane has been researched along with cyanoginosin lr in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chung, FL; Dai, G; Gan, N; Mi, L; Song, L; Sun, X | 1 |
Chung, FL; Gan, N; Liu, J; Mi, L; Song, L; Sun, X | 1 |
2 other study(ies) available for sulforaphane and cyanoginosin lr
Article | Year |
---|---|
Sulforaphane protects Microcystin-LR-induced toxicity through activation of the Nrf2-mediated defensive response.
Topics: Animals; Antioxidants; Apoptosis; Glutathione; Hep G2 Cells; Humans; Isothiocyanates; Marine Toxins; Metabolic Detoxication, Phase II; Mice; Microcystins; NF-E2-Related Factor 2; NIH 3T3 Cells; Protective Agents; Rats; Sulfoxides; Thiocyanates; Water Purification | 2010 |
Sulforaphane prevents microcystin-LR-induced oxidative damage and apoptosis in BALB/c mice.
Topics: Animals; Apoptosis; Cytochrome P-450 CYP2E1; Glutathione; Inflammation; Isothiocyanates; Liver; Male; Marine Toxins; Mice; Mice, Inbred BALB C; Microcystins; NF-E2-Related Factor 2; Oxidative Stress; Sulfoxides; Thiocyanates; Tumor Necrosis Factor-alpha | 2011 |